Wendy S. Rubinstein, MD, PhD, FACMG, FACP
CancerLinQ LLC, a wholly owned nonprofit subsidiary of ASCO, has announced that Wendy S. Rubinstein, MD, PhD, FACMG, FACP, will be its first Division Director, Clinical Data Management and Curation. Dr. Rubinstein will oversee the team working to securely process and analyze the CancerLinQ® platform’s patient data from millions of electronic health records to give personalized insights than can improve the quality of care for patients with cancer.
“Data quality is CancerLinQ’s highest priority and represents the cornerstone of our commitment to the oncology community,” said CancerLinQ LLC Chief Executive Officer Kevin Fitzpatrick. “We are thrilled to have Dr. Rubinstein leading our efforts to develop the highest-quality data set available in oncology. Additionally, we are excited to expand CancerLinQ’s capabilities by adding Dr. Rubinstein’s knowledge and expertise in the field of medical genetic testing.”
Dr. Rubinstein will direct all clinical data quality and data curation efforts for the rapidly growing CancerLinQ database, which currently includes practices in 40 states and the District of Columbia, and CancerLinQ Discovery™—anonymized, statistically deidentified, fit-for-purpose clinical data sets derived from the CancerLinQ platform to support hypothesis-based research.
Prior Leadership Roles
Prior to joining CancerLinQ LLC, Dr. Rubinstein held several roles at the National Institutes for Health (NIH), including Senior Scientist; Chief, Medical Genetics and Human Variation National Center for Biotechnology Information; and Director, NIH Genetic Testing Registry. Before leading at NIH, Dr. Rubinstein spent more than a decade at NorthShore University HealthSystem’s Evanston Hospital—a CancerLinQ vanguard practice—as Chief of the Division of Genetics and Director of the Center for Medical Genetics. She also has served as Clinical Associate Professor of Medicine at the University of Chicago Pritzker School of Medicine and Adjunct Associate Professor of Medicine at Northwestern University.
Dr. Rubinstein holds certification from the American Board of Internal Medicine and the American Board of Medical Genetics. For the latter, she holds dual board certification in clinical genetics and clinical molecular genetics.
Dr. Rubinstein earned her medical degree from the Mount Sinai School of Medicine (now the Icahn School of Medicine at Mount Sinai) and a PhD in biomedical sciences from The City University of New York. ■